Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abiomed, Castle Biosciences, Conformal Medical, Heartflow, Photocure.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adaptimmune, Amarin, Amylyx, Arch, Avalyn, Faron, Galapagos, Imara, Lipella, Pharmamar, Respira, Rocket, Y-mabs, Zynerba.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Abiomed, Dayzz, Infraredx, Philips, Ra Medical Systems.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anavex, Apellis, Astex, Castle Creek, Eiger, GNT, Ionis, J&J, Janssen, Kalvista, Lysogene, Oryzon, Otsuka, Regenrx, Regulus, Sage, Vertex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abiomed, Cardiovascular Systems, Nuvera Medical, Podimetrics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amolyt, Anaptysbio, Auris, Azurrx, Basilea, Bone Therapeutics, Celldex, Cyclerion, Cytoagents, Evelo, Horizon, Ionis, Linnaeus, Mesoblast, Noxxon, Revance, Shasqi, TLC.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astellas, Astrazeneca, Caladrius, Celltrion, Chromadex, CSL Behring, Eli Lilly, Emergent Biosolutions, Gilead Sciences, Glaxosmithkline, Grifols, Napajen, Noxopharm, Redhill Biopharma, Rigel, Seagen, Takeda, University of Oxford, Vir, Zai Lab.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Pixcell Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Algernon, Boehringer, Cytrx, Evelo, Gossamer, Humanigen, J&J, Lineage Cell, Mesoblast, Moleculin, Nabriva, Nanobiotix, Nasus, Neurorx, Regeneron, Relief, Sanofi, Targovax, Uniqure, Vaxart.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Livanova, Lunit, Masimo.